Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
Postprint
DOI
PMC
 |
Open Access Hybrid |
|
as soon as is submitted to ZB.
Implementation of dupilumab in routine care of atopic eczema. Results from the German national registry TREATgermany.
Br. J. Dermatol., DOI: 10.1111/bjd.18958 (2020)
The German atopic eczema (AE)-registry TREATgermany is a non-interventional multicenter patient cohort study for adult patients with currently moderate-to-severe disease activity or current/previous anti-inflammatory systemic treatment.1,2 Dupilumab has demonstrated to be an effective treatment for patients with moderate-to-severe AE in clinical trials.3-5 Real world evidence is now needed to evaluate its effectiveness and safety in routine care.
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
7.000
1.714
25
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Language
english
Publication Year
2020
HGF-reported in Year
2020
ISSN (print) / ISBN
0007-0963
e-ISSN
1365-2133
Publisher
Wiley
Reviewing status
Peer reviewed
Institute(s)
Institute for Allergy Research (IAF)
POF-Topic(s)
30503 - Chronic Diseases of the Lung and Allergies
30202 - Environmental Health
30202 - Environmental Health
Research field(s)
Allergy
PSP Element(s)
G-509000-008
G-522200-001
G-522200-001
PubMed ID
32068242
Erfassungsdatum
2020-03-18